NCT05317520

Brief Summary

To determine the effect of cold vapor given in the post-extubation period on sore throat.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 16, 2016

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 17, 2017

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 17, 2018

Completed
3.2 years until next milestone

First Submitted

Initial submission to the registry

July 27, 2021

Completed
8 months until next milestone

First Posted

Study publicly available on registry

April 7, 2022

Completed
Last Updated

April 14, 2022

Status Verified

April 1, 2022

Enrollment Period

8 months

First QC Date

July 27, 2021

Last Update Submit

April 7, 2022

Conditions

Keywords

ExtubationSore throatCold vaporNursing

Outcome Measures

Primary Outcomes (4)

  • Sore throat

    In our study, a horizontally prepared Numerical Rating Scale was used to evaluate the severity of pain. Patients participating in the study were asked to rate the severity of their sore throat on a scale of 0 to 10. The scale begins with the absence of pain (0) and ends with excruciating pain (10). When the patient came to the recovery unit, the severity of sore throat was evaluated before and after the application of cold vapor at 0th hour.

    Within an hour after surgery

  • Sore throat

    In our study, a horizontally prepared Numeric Rating Scale was used to evaluate the severity of pain. Patients participating in the study were asked to rate the severity of sore throat between 0 and 10. The scale starts with the absence of pain (0) and ends with unbearable pain (10). The severity of sore throat was evaluated before and after the application of cold vapor at 2nd hour postoperatively.

    2nd hour after surgery

  • Sore throat

    In our study, a horizontally prepared Numeric Rating Scale was used to evaluate the severity of pain. Patients participating in the study were asked to rate the severity of sore throat between 0 and 10. The scale starts with the absence of pain (0) and ends with unbearable pain (10). The severity of sore throat was evaluated before and after the application of cold vapor at 6th hour postoperatively.

    6th hour after surgery

  • Sore throat

    In our study, a horizontally prepared Numeric Rating Scale was used to evaluate the severity of pain. Patients participating in the study were asked to rate the severity of sore throat between 0 and 10. The scale starts with the absence of pain (0) and ends with unbearable pain (10). Cold vapor was not applied to the patients at the 24th hour.. Only sore throat were evaluated.

    24th hour after surgery

Secondary Outcomes (8)

  • Hoarseness

    Within an hour after surgery

  • Hoarseness

    2nd hour after surgery

  • Hoarseness

    6th hour after surgery

  • Hoarseness

    24th hour after surgery

  • Dry throat and swallowing difficulty

    Within an hour after surgery

  • +3 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

Cold vapor was applied 3 times in total at 0th,2nd and 6th hours.

Procedure: Cold vapor

Control group

NO INTERVENTION

No cold vapor was applied at 0th,2nd and 6th hours.

Interventions

Cold vaporPROCEDURE

The Ramsey Sedation Scale was used to assess wakefulness after patients were extubated and arrived at the recovery unit at the 0th hour postoperatively. Sore throat, localization of pain, hoarseness, dry throat, and swallowing difficulty were evaluated in patients with a score of 2 according to this scale. Sore throat of the patients was evaluated with Numerical Rating Scale. Then, cold vapor was applied for 15 minutes with a vapor machine used as a standard in the hospital by the researcher. After the cold vapor application was finished, the patients' sore throat, localization of pain, hoarseness, swallowing difficulty and dry throat were re-evaluated with the same forms. Sore throat were evaluated before the application of cold vapor at the 2nd and 6th hours. Then cold vapor was applied for 15 minutes. After the cold vapor application was finished, sore throat were re-evaluated. At the 24th hour, cold vapor was not applied to the patients. Only sore throat were evaluated.

Intervention group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Those who accept the research
  • Elective laparoscopic cholecystectomy surgery planned
  • Patients in ASA I and II class
  • years and over
  • Mallampati classification I and II
  • Operation time more than 30 minutes
  • Literate
  • No hearing problem
  • Patients without understanding difficulties

You may not qualify if:

  • Overweight patients (Body Mass Index ≥ 40)
  • Patients with sore throat and lower respiratory tract infection
  • Patients with Chronic Obstructive Pulmonary Disease (COPD)
  • Patients with a history of allergies
  • Patients with hearing problems
  • illiterate patients
  • ASA classification III and above
  • Mallampati classification III and IV patients
  • Patients with an operation time of less than 30 minutes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hatice Özsoy

Merkez, Burdur, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pharyngitis

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsPharyngeal DiseasesStomatognathic DiseasesRespiratory Tract DiseasesOtorhinolaryngologic Diseases

Study Officials

  • Hatice Özsoy

    Burdur Mehmet Akif Ersoy University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Patients were divided into intervention and control groups using a simple randomized control method.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

July 27, 2021

First Posted

April 7, 2022

Study Start

December 16, 2016

Primary Completion

August 17, 2017

Study Completion

May 17, 2018

Last Updated

April 14, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will share

The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Shared Documents
CSR
Time Frame
6 months after publication
Access Criteria
Relevance to the topic of the study and approval of all co-authors within 1 month of receiving the request.

Locations